Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 8097698 Derivatives of GLP-1 analogs

Patent 8097698 was granted and assigned to Novo Nordisk on January, 2012 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Novo Nordisk
Novo Nordisk
0
Date Filed
November 26, 2007
0
Date of Patent
January 17, 2012
0
Patent Application Number
11944757
0
Patent Citations Received
‌
US Patent 11884713 Acylated glucagon analogues
0
‌
US Patent 11759503 Compositions of GLP-1 peptides and preparation thereof
‌
US Patent 11759502 Compositions of GLP-1 peptides and preparation thereof
‌
US Patent 11759501 Compositions of GLP-1 peptides and preparation thereof
‌
US Patent 11833248 Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid
0
Patent Inventor Names
Soren Erik Bjorn
0
Freddy Zimmerdahl Pedersen
0
Helle Birk Olsen
0
Kjeld Madsen
0
Liselotte Bjerre Knudsen
0
Niels C. Kaarsholm
0
Per Franklin Nielsen
0
Per Olaf Huusfeldt
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
8097698
0
Patent Primary Examiner
‌
David Lukton
0

Find more entities like US Patent 8097698 Derivatives of GLP-1 analogs

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo